GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Payments to Suppliers for Goods and Services

AFT Pharmaceuticals (ASX:AFP) Payments to Suppliers for Goods and Services : A$-147.9 Mil (TTM As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is AFT Pharmaceuticals Payments to Suppliers for Goods and Services?

AFT Pharmaceuticals's Payments to Suppliers for Goods and Services for the six months ended in Sep. 2023 was A$-86.5 Mil.

AFT Pharmaceuticals's Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Sep. 2023 was A$-147.9 Mil.


AFT Pharmaceuticals Payments to Suppliers for Goods and Services Historical Data

The historical data trend for AFT Pharmaceuticals's Payments to Suppliers for Goods and Services can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals Payments to Suppliers for Goods and Services Chart

AFT Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Payments to Suppliers for Goods and Services
Get a 7-Day Free Trial -80.03 -81.88 -100.82 -106.48 -124.45

AFT Pharmaceuticals Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Payments to Suppliers for Goods and Services Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.63 -50.84 -60.18 -61.36 -86.50

AFT Pharmaceuticals Payments to Suppliers for Goods and Services Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Payments to Suppliers for Goods and Services represents cash paid to suppliers when purchasing goods or services by the company in the direct cash flow method.

Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-147.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AFT Pharmaceuticals (ASX:AFP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (ASX:AFP) » Definitions » Payments to Suppliers for Goods and Services
Traded in Other Exchanges
Address
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (ASX:AFP) Headlines

No Headlines